The Study of Recombinant BCG and Interleukin-12 DNAVaccines for Immunogene therapy of Bladder Cancer
博士 === 國防醫學院 === 生命科學研究所 === 92 === Intravesical immunotherapy with live Mycobacterium bovis bacillus Calmette—Guérin (BCG) is the treatment of choice for superficial bladder cancers. Nevertheless, a significant proportion of patients do not respond to this therapy, and adverse effects ar...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2003
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/18256985228943852909 |